Bullish Moving Averages
15
Bearish Moving Averages
1
Back Stocks profile
Open Price
1220.00Prev. Close
1247.7000Volume
113709.00Value
136899950.55Market Cap
23665.20
Price to Earnings
37.60
Price to Book Value
4.90
Dividend Yield
0.90
PE to Growth
2.00
Op Revenue TTM
6304.21
Net Profit TTM
629.92
Cash From Operating Activity
803.20
Return on Equity %
12.78
EMA & SMA
Bullish Moving Averages
15
Bearish Moving Averages
1
DELIVERY AND VOLUME
12 Sep, 2024
Week
Month
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
PIVOT
First Resistance
1259.53
Second Resistance
1302.22
Third Resistance
1326.43
First Support
1192.63
Second Support
1168.42
Third Support
1125.73
Relative Strength Index
61.96
Money Flow Index
82.51
MACD
29.39
MACD Signal
12.7
Average True Range
55.9
Average Directional Index
24.71
Rate of Change (21)
13.92
Rate of Change (125)
24.39
Day Commodity Channel Index
176.1
Day Williams %R
-24.2
BETA
1 Month
0.87
3 Month
0.19
1 Year
0.69
3 Year
0.22
PRICE CHANGE ANALYSIS
1 Week
Low
High
1101.25
1278
1 Month
Low
High
1025.1
1278
3 Months
Low
High
837.8
1284.95
6 Months
Low
High
823.4
1284.95
1 Year
Low
High
707.15
1284.95
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find attached herewith the Intimation received from our RTA.Alembic Pharma Gets USFDA Approval For Drug That Treats Worm Infections
Albendazole tablets are indicated for the treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, Taenia solium.ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Alembic Pharmaceuticals receives USFDA Final Approval for Albendazole Tablets USP, 200 mg.ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find attached herewith the intimation received from our RTA.ALEMBIC PHARMACEUTICALS LTD. - 533573 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
The Company has received an Assessment Order from Office of the Deputy Commissioner of State Tax, Sector - 09, Lucknow, Uttar Pradesh.ALEMBIC PHARMACEUTICALS LTD. - 533573 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
The Company has received an assessment order from the office of Deputy Commissioner of Commercial Taxes, DGSTO-2, Bengaluru, Karnataka.ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Please find attached herewith the Intimation for the Analyst / Fund Manager / Investor MeetAlembic Pharma shares rise after USFDA approval; check details here
Shares of Alembic Pharmaceuticals soared up to 4.13 per cent at Rs 1,135 per share on the BSEALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Alembic Pharmaceuticals receives USFDA Final Approval for Betamethasone Valerate Foam, 0.12%.ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Change in Management
Resignation of SMPThe latest market price of Alembic Pharmaceuticals Ltd. on NSE was Rs. 1203.95 as of today.
The opening share price of Alembic Pharmaceuticals Ltd. was Rs. 1220.00 as of today.
The 52-week high share price of Alembic Pharmaceuticals Ltd. was Rs. 1285.00.
The 52 week low share price of Alembic Pharmaceuticals Ltd. was Rs. 707.20.
The PE ratio of Alembic Pharmaceuticals Ltd. is 2.00. Please refer to the Fundamentals section for further details.
Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.
Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.
The latest dividend declared by Alembic Pharmaceuticals Ltd. was on 2024-07-15 for Rs. 11 per share. According to today’s share price, the dividend yield of Alembic Pharmaceuticals Ltd. stands at 0.90. Please refer to the Corporate Actions section for further details.
Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.
Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.
Please refer to the News section for the latest news about Alembic Pharmaceuticals Ltd..